LB Pharmaceuticals granted inducement stock options to its new Chief Medical Officer and Chief Financial Officer. Each received options for 200,000 shares at $37.22, vesting over four years. The grants are standard equity awards to attract senior executives.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
